drugset / Trial / NCT04581876
The Safety and Efficacy of the Combination of Raltitrexed for Injection and Nab-Paclitaxel in Advanced Pancreatic Cancer
NaSingle-groupOpen-labelTreatment
Summary
The present study is intended to investigate the safety and efficacy of the patients with confirmed advanced pancreatic cancer after treating with the combination of raltitrexed for injection and nab-paclitaxel.
Timeline
- Start
- 2019-11-01
- Primary completion
- 2022-09-01
- Completion
- 2023-03-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Paclitaxel | Small molecule | 125 mg/m2 | — |
| Subject | Raltitrexed | Small molecule | 2 mg/m2 | Intravenous |